David Mehalick Insider Profile

11 Followers
David Mehalick, CEO and President, Director, Ten Percent Owner at Coeptis Therapeutics, holds 2.78M shares in Coeptis Therapeutics Holdings (Ticker: COEP), holds 1.80M shares in Coeptis Therapeutics (Ticker: ~COEP). Most recently, David Mehalick Bought ― shares of Coeptis Therapeutics Holdings on Jan 09, 2024 for an estimated value of 16.75K.
tipranks
David Mehalick

David Mehalick
Coeptis Therapeutics (~COEP)
CEO and President, Director, Ten Percent Owner

Not Ranked
David Mehalick has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$565K
100.00%
A breakdown of David Mehalick's holdings

Insider Roles

Coeptis Therapeutics Holdings
(COEP)
CEO & President, Director, Ten Percent Owner
Roles that David Mehalick holds in companies

Most Profitable Insider Trade

Stock:
Coeptis Therapeutics Holdings
(COEP)
Rating:Informative Buy
Date:Jan 09, 2024 - Today
Return:-68.80%
The most profitable trade made by David Mehalick

David Mehalick's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
~COEP
Coeptis Therapeutics
Nov 18, 2021
Uninformative Sell
$6.03M
Coeptis Therapeutics Holdings
Jan 09, 2024
CEO & President, Director, Ten Percent Owner
Informative Buy
16.75K
$564.87K
List of latest transactions for each holding click on a transaction to see David Mehalick's performance on stock

David Mehalick insider profile FAQ

What is the percentage of profitable transactions made by David Mehalick?
The percentage of profitable transactions made by David Mehalick is ―.
    What is the average return per transaction made by David Mehalick?
    The average return per transaction made by David Mehalick is ―.
      What stocks does David Mehalick hold?
      David Mehalick holds: ~COEP, COEP stocks.
        What was David Mehalick’s latest transaction?
        David Mehalick latest transaction was an Informative Buy of $16.75K.
          What was David Mehalick's most profitable transaction?
          David Mehalick’s most profitable transaction was an Informative Buy of COEP stock on January 9, 2024. The return on the trade was -68.80%.
            What is David Mehalick's role in Coeptis Therapeutics?
            David Mehalick's role in Coeptis Therapeutics is CEO and President, Director, Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.